Gathering data to use it to improve care delivery is easier said than done, explained Charles Saunders, MD, CEO of Integra Connect.
Gathering data to use it to improve care delivery is easier said than done, explained Charles Saunders, MD, CEO of Integra Connect.
Transcript
Technology has led to greater data collection: how can practices ensure they are gathering data and using it in a meaningful way?
Well, the first part is gathering it. And that’s not as easy as it might seem. It’s not just a matter of reporting measures out of the electronic health record (EHR). In many cases, measures that are important—either for calculating quality measures or MIPS [Merit-based Incentive Payment System] measures—may not even be in the electronic health record in a structured format. So, they need to be somehow captured, either through natural language processing or through manual data abstraction. So, the data curation part of it can be very tricky.
In addition to that, if they have holistic responsibilities for patients with the Oncology Care Model, they also need to have claims. They need to integrate claims from CMS and understand those claims and link those to the clinical information from the EHR and other sources of pharmacy, lab, etc. And that requires integrative technology.
How is technology being used to identify inefficiencies?
Well, one of the most useful things that can be done is to take the CMS claims and to identify cost and utilization of services. So, that means acute care days, SNF [skilled nursing facility] days, avoidable emergency department visits, as well as hospice use and other high-cost, high-tech services, and specialty drugs. And the use of those and the units of service can be determined from the CMS claims data and compared against benchmarks to determine whether or not there are savings opportunities, and whether they’re efficient and not efficient and the use of those services.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More